The role of MAP kinases in the induction of iNOS expression in neutrophils exposed to NDMA: The involvement transcription factors

Advances in Medical Sciences

Volumn 58, Issue 2, 2013, Pages 265-273

  Ratajczak Wrona, W ^a   Jablonska, E ^a   Garley, M ^a   Jablonski, J ^a   Radziwon, P ^a,b   Iwaniuk, A ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Centre for Transfusion Medicine   (Poland)

Author keywords

AP 1 (c Jun; c Fos); Inducible nitric oxide synthase (iNOS); N nitrosodimethylamine (NDMA); Neutrophils (PMNs); NF B (p65); Nitric oxide (NO)

Indexed keywords

DIMETHYLNITROSAMINE; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; HUMAN; HUMAN CELL; MIDDLE AGED; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; YOUNG ADULT;

ADULT; DIMETHYLNITROSAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 7; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; XENOBIOTICS;

EID: 84896690812     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-012-0074-y     Document Type: Article

References (49)

1. Aiub CA, Gadermaier G, Oliveira I, Felzenszwalb I, Ferreira F, Ribeiro Pinto LF, Eckl P. N-Nitrosodiethylamine genotoxicity in primary rat hepatocytes: effects of cytochrome P450 induction by phenobarbital. Toxicol Lett. 2011 Oct 10;206(2):139-43.
2. Lijinsky W. Chemistry and biology of N-nitroso compounds. Cambridge: Cambridge University Press; 1992. 480p.
3. Tricker AR, Preussmann R. Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential. Mutat Res. 1991 Mar-Apr;259(3-4):277-89.
4. Hebels DG, Jennen DG, van Herwijnen MH, Moonen EJ, Pedersen M, Knudsen LE, Kleinjans JC, de Kok TM. Whole-genome gene expression modifications associated with nitrosamine exposure and micronucleus frequency in human blood cells. Mutagenesis. 2011 Nov;26(6):753-61.
5. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995 Jun 29;93(1):17-48.
6. Holsapple MP, Bick PH, Duke SS. Effects of N-nitrosodimethylamine on cell-mediated immunity. J Leukoc Biol. 1985 Apr;37(4):367-81. (Pubitemid 15147520)
7. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000 May;80(5):617-53.
8. Jablonski J, Jablonska E, Leonik A. The Effect of N-nitrosodimethylamine (NDMA) on Bax and Mcl-1 expression in human neutrophils. Bull Environ Contam Toxicol. 2011 Dec;87(6):638-42.
9. Kroncke KD, Fehsel K, Kolb-Bachofen V. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem. 1995 Jun;376(6):327-43.
10. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase - time for reappraisal. Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):89-108.
11. Guan Z, Buckman SY, Springer LD, Morrison AR. Both p38αMAPK and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-b in rat glomerular mesangial cells. J Biol Chem. 1999 Dec;274(51):36200-26.
12. Roux PP, Blenis J. ERK and p38 MAPKactivated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44. (Pubitemid 38756868)
13. Zhang Y, Dong C. Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci. 2007 Nov;64(21):2771-89. (Pubitemid 351152255)
14. Ratajczak-Wrona W, Jablonska E, Jablonski J, Marcinczyk M. Induction of expression of iNOS by N-nitrosodimethylamine (NDMA) in human leukocytes. Immunopharmacol Immunotoxicol. 2009;31(4):661-8.
15. Ratajczak-Wrona W, Jablonska E, Garley M, Jablonski J, Radziwon P. Effect of N- nitrosodimethylamine on inducible nitric oxide synthase expression and production of nitric oxide by neutrophils and mononuclear cells: the role of JNK signalling pathway. APMIS. 2011 Jul;119(7):431-41.
16. Ratajczak-Wrona W, Jablonska E, Garley M, Jablonski J, Radziwon P. Role of ERK1/2 kinase in the expression of iNOS by NDMA in human neutrophils. Indian J Exp Biol. 2013 Jan;51(1):73-80.
17. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med. 1996 Oct;74(10):589-607. (Pubitemid 26343761)
18. Pearson G, Robinson F, Gibson TB, Xu B, Karandikar M, Berman K, Cobb MH. Mitogen-Activated Protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001 Apr;22(2):153-83. (Pubitemid 32458157)
19. Karin M. The Regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995 Jul;270(28):16483-6.
20. Foletta VC, Segal DH, Cohen DR. Transcriptional regulation in the immune system: all roads lead to AP-1. J Leukoc Biol. 1998 Feb;63(2):139-52. (Pubitemid 28116496)
21. Bonizzi G, Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004 Jun;25(6):280-8. (Pubitemid 38610351)
22. Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I. NF-kB regulation in human neutrophils by nuclear IkBα: Correlation to apoptosis. J Immunol. 2002 Oct;169(7):3947-53.
23. Trelease RB, Henderson RA, Park JB. A qualitative process system for modeling NF-kappaB and AP-1 gene regulation in immune cell biology research. Artif Intell Med. 1999 Nov;17(3):303-21. (Pubitemid 32872058)
24. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002 May;4(5):E131-6. (Pubitemid 34521026)
25. Marks-Konczalik J, Chu SC, Moss J. Cytokinemediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kB-binding sites. J Biol Chem. 1998 Aug;273(35):22201-8. (Pubitemid 28399774)
26. Xu W, Liu LZ, Loizidou M Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res. 2002 Dec;12(5- 6):311-20. (Pubitemid 135708343)
27. Jablonska E, Puzewska W, Charkiewicz M. Effect of IL-18 on leukocyte expression of iNOS and phospho-IkB in patients with squamous cell carcinoma of the oral cavity. Neoplasma. 2006;53(3):200-5. (Pubitemid 43844377)
28. Jablonska E, Slodczyk B, Wawrusiewicz-Kurylonek N, Garley M, Dziemianczyk D, Kretowski A, Grabowska SZ. Overexpression of B cell-activating factor (BAFF) in neutrophils of oral cavity cancer patients - preliminary study. Neoplasma. 2011;58(3):211-6.
29. Zeman K, Tchorzewski H, Majewska E. Prosta i szybka metoda jednoczesnej izolacji limfocytow i granulocytow krwi obwodowej [Simple and fast method of simultaneous isolation of lymphocytes and the polymorphonuclear cells from peripheral blood] Immunol Pol. 1988;13:217-20. Polish.
30. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994 Dec 22- 29;372(6508):739-46.
31. Tatake RJ, O'Neill MM, Kennedy CA, Wayne AL, Jakes S, Wu D, Kugler SZ Jr, Kashem MA, Kaplita P, Snow RJ. Identification of pharmacological inhibitors of the MEK5/ ERK5 pathway. Biochem Biophys Res Commun. 2008 Dec 5;377(1):120-5.
32. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13681-6. (Pubitemid 33115958)
33. Schulz K, Kerber S, Kelm M. Reevaluation of the Griess method for determining NO/NO2- in aqueous and protein-containing samples. Nitric Oxide. 1999 Jun;3(3):225-34 (Pubitemid 29393462)
34. Janssen YM, Matalon S, Mossman BT. Differential induction of c-fos, c-jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. Am J Physiol. 1997 Oct;273(4 Pt 1):L789-96.
35. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004 Sep 15;18(18):2195-224.
36. Mollinedo F, Vaquerizo MJ, Naranjo JR. Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes. Biochem J. 1991 Jan 15;273(Pt 2):477-9.
37. Cloutier A, Ear T, Borissevitch O, Larivée P, McDonald PP. Inflammatory cytokine expression is independent of the c-Jun N-Terminal Kinase/AP-1 signaling cascade in human neutrophils. J Immunol. 2003 Oct;171(7):3751-61. (Pubitemid 37254580)
38. Biedermann IW. MAP kinases and their role in regulation of protein level, subunit composition and degree of phosphorylation of transcription factor AP-1. Postepy Biochem. 1996;42(3):244-52. Polish.
39. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996 Apr;8(2):205-15. (Pubitemid 26109094)
40. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997 Apr;9(2):240-6. (Pubitemid 27135992)
41. von Knethen A, Callsen D, Brüne B. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell. 1999 Feb;10(2):361-72. (Pubitemid 29156478)
42. Han TH, Prywes R. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol Cell Biol. 1995 Jun;15(6):2907-15.
43. Marinissen MJ, Chiariello M, Pallante M, Gutkind JS. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signalregulated kinase [5] Mol Cell Biol. 1999 Jun;19(6):4289-301. (Pubitemid 29242004)
44. Nishimoto S, Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 2006 Aug;7(8):782-6. (Pubitemid 44275395)
45. Reddy SP, Mossman BT. Role and regulation of activator protein-1 in toxicant-induced responses of the lung. Am J Physiol Lung Cell Mol Physiol. 2002 Dec;283(6):L1161-78. (Pubitemid 35379247)
46. Zwacka RM, Zhang Y, Zhou W, Halldorson J, Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology. 1998 Oct;28(4):1022-30. (Pubitemid 28450263)
47. Kang KW, Choi SY, Cho MK, Lee CH, Kim SG. Thrombin induces nitric-oxide synthase via Gα12/13-coupled protein kinase C-dependent I-κBα phosphorylation and JNK-mediated I-κBα degradation. J Biol Chem. 2003 May;278(19):17368-78. (Pubitemid 36799622)
48. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch SC, Billstrom MA, Henson PM, Johnson GL, Worthen GS. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest. 1999 Mar;103(6):851-8. (Pubitemid 29152631)
49. Lahti A, Jalonen U, Kankaanranta H, Moilanen E. c-Jun NH2-terminal kinase inhibitor anthra(1,9- cd)pyrazol-6(2H)-one reduces inducible nitric oxide synthase expression by destabilizing mRNA in activated macrophages. Mol Pharmacol. 2003 Aug;64(2):308-15. (Pubitemid 36909994)